European Archives - Page 531 of 1053 - European Medical Journal

Biological and Clinical Impacts of Ultraviolet-A on the Skin: New Insights

Terrestrial solar UVR consists of UVA (320–400 nm) and UVB (280–320 nm; typically around 295–320nm because of attenuation by the ozone…

EMJ Dermatology 9 [Supplement 2] 2021

“Biological and Clinical Impacts of Ultraviolet-A on the Skin: New Insights” is a review of the scientific symposium that took place during the 29th…

Talking to Kevin O'Brien

Kevin O’Brien, President, North America, Merz Therapeutics, talks about the intricacies of developing a treatment for a new indication.

EMJ Podcast: COVID-19’s Impact on Atopic Dermatitis

Dr. Miriam Wittmann, Associate Professor, Inflammatory Skin Diseases, The University of Leeds, focuses on COVID-19’s impact on atopic dermatitis.

Physical Activity Level and Factors Affecting Exercise Participation among Nigerian Adults with and Without Diabetes

Noncommunicable diseases (NCD) account for approximately 71% of all deaths globally. Cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes are the four most important NCD and contributors to the burden of disease…

EMJ Podcast: Sky High Health

Jonathan talks to Richard Jenkins, Chief Medical Officer, Emirates, to discuss innovation in healthcare, the impact of COVID-19 on the aviation sector, and how to safeguard the physical and mental health of pilots and cabin crew as they face the greatest challenge to commercial aviation in recent history.

Faecal Microbiome Differences in Healthy and Food-allergic Twins

FOOD allergy affects up to 26 million members of the European population and poses a substantial public health burden. Fortunately, researchers from…

Could a Novel Immunotherapy Approach Help Combat Cat Allergy?

CAT allergies are among the most common allergies, affecting between 10 and 20% of the global population. Symptoms range from mild-to-moderate conditions…

Clinical Presentation and Management of Non-Dystrophic Myotonias

This webinar provides practical guidance for diagnosing and managing non-dystrophic myotonia (NDM), and is particularly aimed at neurologists not specifically specialised in neuromuscular disease.

TDM and T2T – Perfect Partners?

This webinar opened with an introduction to therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD) by Dr Baert, as well as an explanation…